Impact of metabolic regulators on the expression of the obesity associated genes FTO and NAMPT in human preadipocytes and adipocytes

PLoS ONE

Volumn 6, Issue 6, 2011, Pages

  Friebe, Daniela ^a   Löffler, Dennis ^a   Schönberg, Maria ^a   Bernhard, Falk ^a   Büttner, Petra ^a   Landgraf, Kathrin ^a   Kiess, Wieland ^a   Körner, Antje ^a  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DEXAMETHASONE; FAT MASS AND OBESITY ASSOCIATED PROTEIN; GLUCOSE; INSULIN; ISOPRENALINE; MESSENGER RNA; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; SOMATOMEDIN C; UNCLASSIFIED DRUG; FTO PROTEIN, HUMAN; PROTEIN;

ADIPOCYTE; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; FTO GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; METABOLIC STRESS; NAMPT GENE; PROADIPOCYTE; SIMPSON GOLABI BEHMEL SYNDROME; SUBCUTANEOUS FAT; TRANSCRIPTION REGULATION; ADIPOGENESIS; ADULT; CYTOLOGY; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; MALE; METABOLISM; MIDDLE AGED; OBESITY;

ADIPOCYTES; ADIPOGENESIS; ADULT; CELL DIFFERENTIATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MALE; MIDDLE AGED; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; OBESITY; PROTEINS; TRANSCRIPTION, GENETIC; YOUNG ADULT;

EID: 79958140016     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0019526     Document Type: Article

References (46)

1. Frayling TM, Timpson NJ, Weedon MN, Zeggini E, Freathy RM, et al. (2007) A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 316 (5826): 889-894 Available: doi:10.1126/science.1141634.
2. Moschen AR, Geiger S, Gerner R, Tilg H, (2010) Pre-B cell colony enhancing factor/NAMPT/visfatin and its role in inflammation-related bone disease. Mutat Res 690 (1-2): 95-101.
3. Dina C, Meyre D, Gallina S, Durand E, Körner A, et al. (2007) Variation in FTO contributes to childhood obesity and severe adult obesity. Nat Genet 39 (6): 724-726 Available: doi:10.1038/ng2048.
4. Scuteri A, Sanna S, Chen W, Uda M, Albai G, et al. (2007) Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits. PLoS Genet 3 (7): e115 Available: doi:10.1371/journal.pgen.0030115.
5. Jowett JBM, Curran JE, Johnson MP, Carless MA, Göring HHH, et al. (2010) Genetic variation at the FTO locus influences RBL2 gene expression. Diabetes 59 (3): 726-732.
6. Richon VM, Lyle RE, McGehee RE, (1997) Regulation and expression of retinoblastoma proteins p107 and p130 during 3T3-L1 adipocyte differentiation. J Biol Chem 272 (15): 10117-10124.
7. Grunnet LG, Nilsson E, Ling C, Hansen T, Pedersen O, et al. (2009) Regulation and function of FTO mRNA expression in human skeletal muscle and subcutaneous adipose tissue. Diabetes 58 (10): 2402-2408 Available: doi:10.2337/db09-0205.
8. Zabena C, González-Sánchez JL, Martínez-Larrad MT, Torres-García A, Alvarez-Fernández-Represa J, et al. (2009) The FTO obesity gene. Genotyping and gene expression analysis in morbidly obese patients. Obes Surg 19 (1): 87-95 Available: doi:10.1007/s11695-008-9727-0.
9. Fischer J, Koch L, Emmerling C, Vierkotten J, Peters T, et al. (2009) Inactivation of the Fto gene protects from obesity. Nature 458 (7240): 894-898 Available: doi:10.1038/nature07848.
10. Speakman JR, Rance KA, Johnstone AM, (2008) Polymorphisms of the FTO gene are associated with variation in energy intake, but not energy expenditure. Obesity (Silver Spring) 16 (8): 1961-1965 Available: doi:10.1038/oby.2008.318.
11. Cecil JE, Tavendale R, Watt P, Hetherington MM, Palmer CNA, (2008) An obesity-associated FTO gene variant and increased energy intake in children. N Engl J Med 359 (24): 2558-2566 Available: doi:10.1056/NEJMoa0803839.
12. Wåhlén K, Sjölin E, Hoffstedt J, (2008) The common rs9939609 gene variant of the fat mass- and obesity-associated gene FTO is related to fat cell lipolysis. J Lipid Res 49 (3): 607-611 Available: doi:10.1194/jlr.M700448-JLR200.
13. Gerken T, Girard CA, Tung YL, Webby CJ, Saudek V, et al. (2007) The obesity-associated FTO gene encodes a 2-oxoglutarate-dependent nucleic acid demethylase. Science 318 (5855): 1469-1472 Available: doi:10.1126/science.1151710.
14. Jia G, Yang C, Yang S, Jian X, Yi C, et al. (2008) Oxidative demethylation of 3-methylthymine and 3-methyluracil in single-stranded DNA and RNA by mouse and human FTO. FEBS Lett 582 (23-24): 3313-3319 Available: doi:10.1016/j.febslet.2008.08.019.
15. Han Z, Niu T, Chang J, Lei X, Zhao M, et al. (2010) Crystal structure of the FTO protein reveals basis for its substrate specificity. Nature 464 (7292): 1205-1209 Available: doi:10.1038/nature08921.
16. Wu Q, Saunders RA, Szkudlarek-Mikho M, La Serna I de, Chin K, (2010) The obesity-associated Fto gene is a transcriptional coactivator. Biochem Biophys Res Commun 401 (3): 390-395.
17. Revollo JR, Körner A, Mills KF, Satoh A, Wang T, et al. (2007) Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme. Cell Metab 6 (5): 363-375 Available: doi:10.1016/j.cmet.2007.09.003.
18. Haider DG, Schaller G, Kapiotis S, Maier C, Luger A, et al. (2006) The release of the adipocytokine visfatin is regulated by glucose and insulin. Diabetologia 49 (8): 1909-1914 Available: doi:10.1007/s00125-006-0303-7.
19. Kreutzenberg SV de, Ceolotto G, Papparella I, Bortoluzzi A, Semplicini A, et al. (2010) Downregulation of the longevity-associated protein sirtuin 1 in insulin resistance and metabolic syndrome: potential biochemical mechanisms. Diabetes 59 (4): 1006-1015 Available: doi:10.2337/db09-1187.
20. Kralisch S, Klein J, Lossner U, Bluher M, Paschke R, et al. (2005) Hormonal regulation of the novel adipocytokine visfatin in 3T3-L1 adipocytes. J Endocrinol 185 (3): R1-8 Available: doi:10.1677/joe.1.06211.
21. Friebe D, Neef M, Kratzsch J, Erbs S, Dittrich K, et al. (2011) Leucocytes are a major source of circulating nicotinamide phosphoribosyltransferase (NAMPT)/pre-B cell colony (PBEF)/visfatin linking obesity and inflammation in humans. Diabetologia.
22. Körner A, Wabitsch M, Seidel B, Fischer-Posovszky P, Berthold A, et al. (2005) Adiponectin expression in humans is dependent on differentiation of adipocytes and down-regulated by humoral serum components of high molecular weight. Biochem Biophys Res Commun 337 (2): 540-550 Available: doi:10.1016/j.bbrc.2005.09.064.
23. Tews D, Fischer-Posovszky P, Wabitsch M, (2010) Regulation of FTO and FTM Expression During Human Preadipocyte Differentiation. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme. Available: doi:10.1055/s-0030-1265130.
24. Koerner A, Kratzsch J, Kiess W, (2005) Adipocytokines: leptin-the classical, resistin-the controversical, adiponectin-the promising, and more to come. Best Pract Res Clin Endocrinol Metab 19 (4): 525-546.
25. Yu Y, Zhu H, (2004) Chronological changes in metabolism and functions of cultured adipocytes: a hypothesis for cell aging in mature adipocytes. Am J Physiol Endocrinol Metab 286 (3): E402-10.
26. Perrini S, Laviola L, Cignarelli A, Melchiorre M, Stefano F de, et al. (2008) Fat depot-related differences in gene expression, adiponectin secretion, and insulin action and signalling in human adipocytes differentiated in vitro from precursor stromal cells. Diabetologia 51 (1): 155-164.
27. Church C, Lee S, Bagg EAL, McTaggart JS, Deacon R, et al. (2009) A mouse model for the metabolic effects of the human fat mass and obesity associated FTO gene. PLoS Genet 5 (8): e1000599 Available: doi:10.1371/journal.pgen.1000599.
28. Zabena C, González-Sánchez JL, Martínez-Larrad MT, Torres-García A, Alvarez-Fernández-Represa J, et al. (2009) The FTO obesity gene. Genotyping and gene expression analysis in morbidly obese patients Obes Surg 19 (1): 87-95 Available: doi:10.1007/s11695-008-9727-0.
29. Gao X, Shin Y, Li M, Wang F, Tong Q, et al. (2010) The fat mass and obesity associated gene FTO functions in the brain to regulate postnatal growth in mice. PLoS ONE 5 (11): e14005.
30. McCarthy TL, Ji C, Chen Y, Kim K, Centrella M, (2000) Time- and dose-related interactions between glucocorticoid and cyclic adenosine 3′,5′-monophosphate on CCAAT/enhancer-binding protein-dependent insulin-like growth factor I expression by osteoblasts. Endocrinology 141 (1): 127-137.
31. Fredriksson R, Hägglund M, Olszewski PK, Stephansson O, Jacobsson JA, et al. (2008) The obesity gene, FTO, is of ancient origin, up-regulated during food deprivation and expressed in neurons of feeding-related nuclei of the brain. Endocrinology 149 (5): 2062-2071 Available: doi:10.1210/en.2007-1457.
32. Boissel S, Reish O, Proulx K, Kawagoe-Takaki H, Sedgwick B, et al. (2009) Loss-of-function mutation in the dioxygenase-encoding FTO gene causes severe growth retardation and multiple malformations. Am J Hum Genet 85 (1): 106-111.
33. Tung YL, Ayuso E, Shan X, Bosch F, O'Rahilly S, et al. (2010) Hypothalamic-specific manipulation of Fto, the ortholog of the human obesity gene FTO, affects food intake in rats. PLoS ONE 5 (1): e8771.
34. Kralisch S, Klein J, Lossner U, Bluher M, Paschke R, et al. (2005) Interleukin-6 is a negative regulator of visfatin gene expression in 3T3-L1 adipocytes. Am J Physiol Endocrinol Metab 289 (4): E586-90 Available: doi:10.1152/ajpendo.00090.2005.
35. MacLaren R, Cui W, Cianflone K, (2007) Visfatin expression is hormonally regulated by metabolic and sex hormones in 3T3-L1 pre-adipocytes and adipocytes. Diabetes Obes Metab 9 (4): 490-497 Available: doi:10.1111/j.1463-1326.2006.00625.x.
36. Yang R, Huang Q, Xu A, McLenithan JC, Eisen JA, et al. (2003) Comparative studies of resistin expression and phylogenomics in human and mouse. Biochem Biophys Res Commun 310 (3): 927-935.
37. Fukuhara A, Matsuda M, Nishizawa M, Segawa K, Tanaka M, et al. (2005) Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 307 (5708): 426-430 Available: doi:10.1126/science.1097243.
38. Urs S, Smith C, Campbell B, Saxton AM, Taylor J, et al. (2004) Gene expression profiling in human preadipocytes and adipocytes by microarray analysis. J Nutr 134 (4): 762-770.
39. Chung S, Lapoint K, Martinez K, Kennedy A, Boysen Sandberg M, et al. (2006) Preadipocytes mediate lipopolysaccharide-induced inflammation and insulin resistance in primary cultures of newly differentiated human adipocytes. Endocrinology 147 (11): 5340-5351 Available: doi:10.1210/en.2006-0536.
40. Harkins JM, Moustaid-Moussa N, Chung Y, Penner KM, Pestka JJ, et al. (2004) Expression of interleukin-6 is greater in preadipocytes than in adipocytes of 3T3-L1 cells and C57BL/6J and ob/ob mice. J Nutr 134 (10): 2673-2677.
41. Fulco M, Cen Y, Zhao P, Hoffman EP, McBurney MW, et al. (2008) Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of Nampt. Dev Cell 14 (5): 661-673 Available: doi:10.1016/j.devcel.2008.02.004.
42. Hayashida S, Arimoto A, Kuramoto Y, Kozako T, Honda S, et al. (2010) Fasting promotes the expression of SIRT1, an NAD+-dependent protein deacetylase, via activation of PPARalpha in mice. Mol Cell Biochem 339 (1-2): 285-292.
43. Revollo JR, Grimm AA, Imai S, (2004) The NAD biosynthesis pathway mediated by nicotinamide phosphoribosyltransferase regulates Sir2 activity in mammalian cells. J Biol Chem 279 (49): 50754-50763 Available: doi:10.1074/jbc.M408388200.
44. Hsu C, Oka S, Shao D, Hariharan N, Sadoshima J, (2009) Nicotinamide phosphoribosyltransferase regulates cell survival through NAD+ synthesis in cardiac myocytes. Circ Res 105 (5): 481-491 Available: doi:10.1161/CIRCRESAHA.109.203703.
45. Obermaier B, Ermel B, Kirsch D, Mushack J, Rattenhuber E, et al. (1987) Catecholamines and tumour promoting phorbolesters inhibit insulin receptor kinase and induce insulin resistance in isolated human adipocytes. Diabetologia 30 (2): 93-99.
46. Sakoda H, Ogihara T, Anai M, Funaki M, Inukai K, et al. (2000) Dexamethasone-induced insulin resistance in 3T3-L1 adipocytes is due to inhibition of glucose transport rather than insulin signal transduction. Diabetes 49 (10): 1700-1708.